T1	eligibility 98 145	breast cancer patients with early-stage disease
T7	control 355 418	mastectomy and doxorubicin-based chemotherapy without radiation
T2	intervention 30 60	doxorubicin-based chemotherapy
T3	intervention 65 79	postmastectomy
T6	total-participants 542 545	470
T9	outcome 907 933	prognostic factors for LRR
T10	outcome 1060 1072	rates of LRR
T4	outcome 1474 1491	predictors of LRR
T5	outcome 1574 1588	positive nodes
T11	outcome 1597 1607	tumor size
T12	outcome 1609 1638	lymphovascular space invasion
T13	outcome 1644 1683	estrogen receptor (ER)-negative disease
T14	outcome 1151 1168	10-year LRR rates
